• 29 Citations
  • 3 h-Index
20152019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessandra Ferrari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Fungemia Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Football Medicine & Life Sciences
Muscle Strength Medicine & Life Sciences
Hematologic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Body Composition Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2015 2019

  • 29 Citations
  • 3 h-Index
  • 5 Article
  • 1 Comment/debate
  • 1 Review article

Fungaemia in haematological malignancies: SEIFEM-2015 survey

the SEIFEM Group (Sorveglianza Epidemiologica Infezioni nelle Emopatie), Criscuolo, M., Marchesi, F., Candoni, A., Cattaneo, C., Nosari, A., Veggia, B., Verga, L., Fracchiolla, N., Vianelli, N., Del Principe, M. I., Picardi, M., Tumbarello, M., Aversa, F., Busca, A. & Pagano, L., Jan 1 2019, In : European Journal of Clinical Investigation. 49, 5, e13083.

Research output: Contribution to journalArticle

Fungemia
Hematologic Neoplasms
Yeast
Catheters
Mycoses
4 Citations (Scopus)

Pazopanib in patients with clear-cell renal cell carcinoma: Seeking the right patient

Porta, C., Ferrari, A., Czarnecka, A. M. & Szczylik, C. A., Jun 21 2017, In : Frontiers in Pharmacology. 8, JUN, 329.

Research output: Contribution to journalComment/debate

3 Citations (Scopus)

Pharmacotherapy for treating metastatic clear cell renal cell carcinoma

Porta, C., Chiellino, S., Ferrari, A., Mariucci, S. & Liguigli, W., Jan 22 2017, In : Expert Opinion on Pharmacotherapy. 18, 2, p. 205-216 12 p.

Research output: Contribution to journalReview article

Renal Cell Carcinoma
Drug Therapy
Expert Testimony
Immunotherapy
Vascular Endothelial Growth Factor A
11 Citations (Scopus)

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi

Zaja, F., Ferrero, S., Stelitano, C., Ferrari, A., Salvi, F., Arcari, A., Musuraca, G., Botto, B., Spina, M., Cellini, C., Patti, C., Liberati, A. M., Minotto, C., Pileri, S. A., Ceccarelli, M., Volpetti, S., Ferranti, A., Drandi, D., Montechiarello, E., Ladetto, M. & 2 others, Carmichael, J. & Fanin, R., 2017, In : Haematologica. 102, 5, p. e203-e206 4 p.

Research output: Contribution to journalArticle